225 LONG AVENUE, HILLSIDE, NJ
Reports Results for its Quarter and Fiscal Year Ended June 30, 2026
WHOLLY-OWNED SUBSIDIARY, MANHATTAN DRUG COMPANY, INC. APPOINTS MICHAEL RICHTMYER AS HEAD OF OPERATIONS
Material Definitive Agreements with Manhattan Drug Company and PNC Bank
Reports Results for its Quarter Ended March 31, 2026
News
Fourth Amendment of Lease with Vitamin Realty Associates Executed
Reports Results for its Quarter Ended December 31, 2025
FY 2025
Q3
Q2
Q1
Registration Statement for Securities to be Offered to Employees
Notice of Exempt Offering of Securities
SEC Form 25 - Delisting Notification
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Amended Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Schedule 13D - Ownership Report
Definitive Revised Proxy Statement
Submission Upload
Correspondence